Table 3 Profile of hypertensive participants
From: Hypertension in Cameroon associated with high likelihood of obstructive sleep apnea: a pilot study
Variable | n | % |
|---|---|---|
50 | 48.1 | |
Number of years since diagnosis | ||
 Mean ± SD | 4.46 ± 4.36 | |
  1–2 | 28 | 56.0 |
  3–5 | 9 | 18.0 |
  > 5 | 13 | 26.0 |
Current treatment strategy | ||
  Non-pharmacological (lifestyle changes only) | 0 | 0.0 |
  Pharmacological only | 10 | 20.0 |
  Both | 40 | 80.0 |
JNC classification of Hypertension | ||
 Normal | 00. | 00 |
 Pre-hypertension | 15 | 30 |
 Stage 1 | 17 | 34 |
 Stage 2 | 18 | 36 |
Complaint to treatment (self-reported) | ||
 No | 2 | 4.0 |
 Yes | 48 | 96.0 |
Frequency of follow-up visits yearly | ||
 Mean ± SD | 3.94 ± 0.59 | |
  1–2 visits | 2 | 4.1 |
  3 or more | 47 | 95.9 |
Other medication on other than anti-HBP | ||
 None | 44 | 88.0 |
 Statins | 4 | 8.0 |
 Warfarin | 1 | 2.0 |
 Other | 1 | 2.0 |
Sleep medication use? | ||
 No | 50 | 100.0 |
HBP control | ||
 Controlled BP (<140/90 mmHg) | 12 | 24.0 |
 Uncontrolled BP (>140/90 mmHg) | 38 | 76.0 |